Jane Street Group, LLC Bridge Bio Pharma, Inc. Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$7.34 - $17.16 $4.1 Million - $9.58 Million	-558,500 Reduced 75.49%	181,300 $1.84 Million
Q4 2021 Feb 15, 2022	BUY	$11.38 - $53.41 $7.25 Million - $34 Million	636,700 Added 617.56%	739,800 $12.3 Million
Q3 2021 Nov 16, 2021	BUY	$46.87 - $64.24 $2.06 Million - $2.82 Million	43,900 Added 74.16%	103,100 $4.83 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $106,881 - $147,039	2,300 Added 4.04%	59,200 $3.61 Million
Q1 2021 May 18, 2021	BUY	$55.47 - $72.35 $2.61 Million - $3.41 Million	47,100 Added 480.61%	56,900 $3.51 Million
Q4 2020 Feb 17, 2021	SELL	$38.38 - $71.11 $990,204 - $1.83 Million	-25,800 Reduced 72.47%	9,800 $697,000
Q2 2020 Aug 17, 2020	BUY	$22.22 - $35.69 $791,032 - $1.27 Million	35,600 New	35,600 $1.16 Million

294

177M

8.72M

2.75M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.84B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.